178
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Multidrug-Resistant Acinetobacter baumannii – The Modern Menace: A Retrospective Study in a Tertiary Hospital in Mangalore

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2181-2187 | Published online: 07 Jul 2020

References

  • Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther. 2015;40(4):277.
  • Schwartz RS. Paul Ehrlich’s magic bullets. N Engl J Med. 2004;350(11):1079–1080. doi:10.1056/NEJMp04802115014180
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: the emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582.18625687
  • Howard A, O’dounoghue M, Feeney A, Sleeator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012;3(3):243–250. doi:10.4161/viru.1970022546906
  • Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249. doi:10.2147/IDR.S16675030174448
  • Al Atrouni A, Joly-Guillou ML, Hamze M, Kempf M. Reservoirs of non-baumannii Acinetobacter species. Front Microbiol. 2016;7:49. doi:10.3389/fmicb.2016.0004926870013
  • Fernández L, Hancock RE. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev. 2012;25(4):661–681. doi:10.1128/CMR.00043-1223034325
  • Alsan M, Klompas M. Acinetobacter baumannii: an emerging and important pathogen. J Clin Outcomes Manag. 2010;17(8):363.26966345
  • Manchanda V, Sanchaita S, Singh NP. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2(3):291. doi:10.4103/0974-777X.6853820927292
  • Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148. doi:10.1128/CMR.9.2.1488964033
  • Rello J, Diaz E. Acinetobacter baumannii: a threat for the ICU? Intensive Care Med. 2003;29(3):350–351. doi:10.1007/s00134-003-1661-y12589534
  • Sileem AE, Said AM, Meleha MS. Acinetobacter baumannii in ICU patients: a prospective study highlighting their incidence, antibiotic sensitivity pattern and impact on ICU stay and mortality. Egypt J Chest Dis Tuberc. 2017;66(4):693–698. doi:10.1016/j.ejcdt.2017.01.003
  • Dent LL, Marshall DR, Pratap S, Hulette RB. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis. 2010;10:196. doi:10.1186/1471-2334-10-19620609238
  • Altun HU, Yagci S, Bulut C, et al. Antimicrobial susceptibilities of clinical Acinetobacter baumannii isolates with different genotypes. Jundishapur J Microbiol. 2014;7(12). doi:10.5812/jjm.13347
  • Eliopoulos GM, Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254–1263. doi:10.1086/52919818444865
  • Ye JJ, Huang CT, Shie SS, et al. Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains. PLoS One. 2010;5(4):e9947. doi:10.1371/journal.pone.000994720369056
  • Blanco N, Harris AD, Rock C, et al. Risk factors and outcomes associated with multidrug-resistant Acinetobacter baumannii upon intensive care unit admission. Antimicrob Agents Chemother. 2018;62(1):e01631–17. doi:10.1128/AAC.01631-17
  • Abbo A, Carmeli Y, Navon-Venezia S, Siegman-Igra Y, Schwaber MJ. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis. 2007;26(11):793–800. doi:10.1007/s10096-007-0371-817701063
  • Fillaux J, Dubouix A, Conil J-M, Laguerre J, Marty N. Retrospective analysis of multidrug-resistant acinetobacter baumannii strains isolated during a 4-year period in a University Hospital. Infect Control Hosp Epidemiol. 2006;27(7):647–653. doi:10.1086/50708216807836
  • Duszynska W, Litwin A, Rojek S, Szczesny A, Ciasullo A, Gozdzik W. Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study. Infect Drug Resist. 2018;11:629. doi:10.2147/IDR.S16223229750043
  • Jung JY, Park MS, Kim SE, et al. Risk factors for multidrug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis. 2010;10(1):228. doi:10.1186/1471-2334-10-22820670453
  • Munier AL, Biard L, Rousseau C, et al. Incidence, risk factors, and outcome of multidrug-resistant Acinetobacter baumannii acquisition during an outbreak in a burns unit. J Hosp Inf. 2017;97(3):226–233. doi:10.1016/j.jhin.2017.07.020
  • Odsbu I, Khedkar S, Khedkar U, Nerkar SS, Tamhankar AJ, Stålsby Lundborg C. High proportions of multidrug-resistant Acinetobacter spp. isolates in a district in Western India: a four-year antibiotic susceptibility study of clinical isolates. Int J Environ Res Public Health. 2018;15(1):153. doi:10.3390/ijerph15010153
  • Khajuria A, Praharaj AK, Kumar M, Grover N. Molecular characterization of carbapenem resistant isolates of Acinetobacter baumannii in an intensive care unit of a tertiary care centre at central India. J Clin Diagn Res. 2014;8(5):DC38. doi:10.7860/JCDR/2014/6788.395624995182
  • Sherwani N, Barapatre R, Neral A, Singh R, Gade N. A study of multidrug-resistant Acinetobacter baumannii – a susceptibility pattern and possible risk factors in a tertiary care hospital of Chattisgarh. J Evol Med Dent Sci. 2018;7(36):3935–3940. doi:10.14260/jemds/2018/880
  • Ruan Z, Feng Y. BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res. 2016;44(D1):D682–D687. doi:10.1093/nar/gkv100426433226